Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
D

DuoGenic StemCells Corp
TPEX:7607

Watchlist Manager
DuoGenic StemCells Corp
TPEX:7607
Watchlist
Price: 8.57 TWD
Market Cap: NT$261.8m
Write Note Create Alert Ask AI
TWD
Metric FY2021 FY2022 FY2023 FY2024 FY2025
Net Income
(22.8m) (33.7m) (45.1m) (61.6m) (26.4m)
Depreciation & Amortization
2.7m 5.3m 7m 7.3m 5.9m
Other Non-Cash Items
3.1m (708k) (1.3m) 317k 666k
Cash Taxes Paid
(56k) — 18k 5k (8k)
Cash Interest Paid
47k 68k 160k 557k 901k
Change in Working Capital
(2.9m) (4.2m) (4.3m) 6.7m 1.4m
Cash from Operating Activities
(20m) (33.4m) (43.7m) (47.3m) (18.5m)
Capital Expenditures
(9m) (12m) (1m) (1.2m) (257k)
Other Items
— — — — (4.6m)
Cash from Investing Activities
(9m) (12m) (1m) (1.2m) (4.9m)
Net Issuance of Common Stock
63.3m 38m 50m — 60.5m
Net Issuance of Debt
(839k) (1.1m) (1.7m) 27.8m (11.6m)
Other
(47k) (68k) (160k) (557k) (901k)
Cash from Financing Activities
62.4m 36.8m 48.1m 27.3m 48m
Net Change in Cash
33.4m (8.6m) 3.5m (21.2m) 24.7m
Free Cash Flow
(29m) (45.4m) (44.7m) (48.5m) (18.7m)
IDLDX
IDL Diagnostics AB (publ)

A growing diagnostics platform with improving margins and uneven cash conversion

Undervalued by 53%
199730
BioInfra Co Ltd

Project-led testing revenue meets heavy research costs and volatile cash conversion

PYC
Physiomics PLC

A low-capital contract-services business still funded through equity issuance

Overvalued by 7%
540729
Vanta Bioscience Ltd

A project-driven research business with volatile earnings and persistent reinvestment needs

Undervalued by 18%

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
ALPHA SPREAD
Follow us
Join 362,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.